Macrolide resistance determinants among Streptococcus pneumoniae isolates from carriers in Central Greece

BMC Infectious Diseases

Volumn 12, Issue , 2012, Pages

  Grivea, Ioanna N ^a   Sourla, Alexia ^a   Ntokou, Eleni ^a   Chryssanthopoulou, Denise C ^a   Tsantouli, Alexandra G ^a   Syrogiannopoulos, George A ^a  

^a UNIVERSITY OF THESSALY   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; COLISTIN; COTRIMOXAZOLE; ERYTHROMYCIN; MACROLIDE; NALIDIXIC ACID; OXACILLIN; PENICILLIN V; PNEUMOCOCCUS VACCINE; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM CARRIER; BACTERIUM ISOLATE; CHILD; ERMB GENE; FEMALE; GENETIC IDENTIFICATION; GENOTYPE; GREECE; HETEROZYGOTE; HUMAN; INFANT; MALE; MEFA GENE; MEFE GENE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; PNEUMOCOCCAL INFECTION; PRESCHOOL CHILD; SEROTYPE; STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; CARRIER STATE; CHILD; CHILD DAY CARE CENTERS; CHILD, PRESCHOOL; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; FEMALE; GENES, BACTERIAL; GREECE; HUMANS; INFANT; MACROLIDES; MALE; MICROBIAL SENSITIVITY TESTS; NASOPHARYNX; PNEUMOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE;

EID: 84867236560     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-12-255     Document Type: Article

References (53)

1. Klein JO. The epidemiology of pneumococcal disease in infants and children. Rev Infect Dis 1981, 3:246-253. 10.1093/clinids/3.2.246, 7020043.
2. Gray BM, Converse GM, Dillon HC. Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life. J Infect Dis 1980, 142:923-933. 10.1093/infdis/142.6.923, 7462701.
3. Faden H, Duffy L, Wasielewski R, Wolf J, Krystofik D, Tung Y, . Tonawanda/Williamsville Pediatrics Relationship between nasopharyngeal colonization and the development of otitis media in children. J Infect Dis 1997, 175:1440-1445. 10.1086/516477, 9180184, Tonawanda/Williamsville Pediatrics.
4. Bogaert D, De Groot R, Hermans PW. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect Dis 2004, 4:144-154. 10.1016/S1473-3099(04)00938-7, 14998500.
5. Lin TY, Shah NK, Brooks D, Garcia CS. Summary of invasive pneumococcal disease burden among children in the Asia-Pacific region. Vaccine 2010, 28:7589-7605. 10.1016/j.vaccine.2010.07.053, 20674872.
6. Dagan R, Givon-Lavi N, Zamir O, Fraser D. Effect of a nonavalent conjugate vaccine on carriage of antibiotic-resistant Streptococcus pneumoniae in day-care centers. Pediatr Infect Dis J 2003, 22:532-540.
7. Cohen R, Levy C, Bonnet E, Grondin S, Desvignes V, Lecuyer A, Fritzell B, Varon E. Dynamic of pneumococcal nasopharyngeal carriage in children with acute otitis media following PCV7 introduction in France. Vaccine 2010, 28:6114-6121. 10.1016/j.vaccine.2009.05.037, 19490958.
8. Grivea IN, Tsantouli AG, Michoula AN, Syrogiannopoulos GA. Dynamics of Streptococcus pneumoniae nasopharyngeal carriage with high heptavalent pneumococcal conjugate vaccine coverage in Central Greece. Vaccine 2011, 29:8882-8887. 10.1016/j.vaccine.2011.09.074, 21963873.
9. Farrell DJ, Morrissey I, Bakker S, Felmingham D. Molecular characterization of macrolide resistance mechanisms among Streptococcus pneumoniae and Streptococcus pyogenes isolated from the PROTEKT 1999-2000 study. J Antimicrob Chemother 2002, 50(Suppl. S1):39-47.
10. Van Eldere J, Meekers E, Lagrou K, Massonet C, Canu A, Devenyns I, Verhaegen J, Syrogiannopoulos G, Leclercq R. Macrolide resistance mechanisms in Streptococcus pneumoniae isolates from Belgium. Clin Microbiol Infect 2005, 11:332-334. 10.1111/j.1469-0691.2005.01077.x, 15760433.
11. Jacobs MR, Good CE, Beall B, Bajaksouzian S, Windau AR, Whitney CG. Changes in serotypes and antimicrobial susceptibility of invasive Streptococcus pneumoniae strains in Cleveland: a quarter century of experience. J Clin Microbiol 2008, 46:982-990. 10.1128/JCM.02321-07, 2268364, 18234877.
12. Farrell DJ, Couturier C, Hryniewicz W. Distribution and antibacterial susceptibility of macrolide resistance genotypes in Streptococcus pneumoniae: PROTEKT Year 5 (2003-2004). Int J Antimicrob Agents 2008, 31:245-249. 10.1016/j.ijantimicag.2007.10.022, 18178388.
13. Jenkins SG, Farrell DJ. Increase in pneumococcus macrolide resistance, United States. Emerg Infect Dis 2009, 15:1260-1264. 10.3201/eid1508.081187, 2815953, 19751588.
14. Imöhl M, Reinert RR, Mutscher C, van der Linden M. Macrolide susceptibility and serotype specific macrolide resistance of invasive isolates of Streptococcus pneumoniae in Germany from 1992 to 2008. BMC Microbiol 2010, 10:299. 10.1186/1471-2180-10-299, 3001718, 21108778.
15. Leclercq R, Courvalin P. Resistance to macrolides and related antibiotics in Streptococcus pneumoniae. Antimicrob Agents Chemother 2002, 46:2727-2734. 10.1128/AAC.46.9.2727-2734.2002, 127415, 12183222.
16. Weisblum B. Erythromycin resistance by ribosome modification. Antimicrob Agents Chemother 1995, 39:577-585. 10.1128/AAC.39.3.577, 162587, 7793855.
17. Ambrose KD, Nisbet R, Stephens DS. Macrolide efflux in Streptococcus pneumoniae is mediated by a dual efflux pump (mel and mef) and is erythromycin inducible. Antimicrob Agents Chemother 2005, 49:4203-4209. 10.1128/AAC.49.10.4203-4209.2005, 1251515, 16189099.
18. Sutcliffe J, Tait-Kamradt A, Wondrack L. Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system. Antimicrob Agents Chemother 1996, 40:1817-1824. 163423, 8843287.
19. Tait-Kamradt A, Clancy J, Cronan M, Dib-Hajj F, Wondrack L, Yuan W, Sutcliffe J. mefE is necessary for the erythromycin-resistant M phenotype in Streptococcus pneumoniae. Antimicrob Agents Chemother 1997, 41:2251-2255. 164101, 9333056.
20. Roberts MC, Sutcliffe J, Courvalin P, Jensen LB, Rood J, Seppala H. Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants. Antimicrob Agents Chemother 1999, 43:2823-2830. 89572, 10582867.
21. Oster P, Zanchi A, Cresti S, Lattanzi M, Montagnani F, Cellesi C, Rossolini GM. Patterns of macrolide resistance determinants among community-acquired Streptococcus pneumoniae isolates over a 5-year period of decreased macrolide susceptibility rates. Antimicrob Agents Chemother 1999, 43:2510-2512. 89509, 10508033.
22. Del Grosso M, Iannelli F, Messina C, Santagati M, Petrosillo N, Stefani S, Pozzi G, Pantosti A. Macrolide efflux genes mef(A) and mef(E) are carried by different genetic elements in Streptococcus pneumoniae. J Clin Microbiol 2002, 40:774-778. 10.1128/JCM.40.3.774-778.2002, 120261, 11880392.
23. Bley C, van der Linden M, Reinert RR. mef(A) is the predominant macrolide resistance determinant in Streptococcus pneumoniae and Streptococcus pyogenes in Germany. Int J Antimicrob Agents 2011, 37:425-431. 10.1016/j.ijantimicag.2011.01.019, 21419605.
24. Santagati M, Iannelli F, Oggioni MR, Stefani S, Pozzi G. Characterization of a genetic element carrying the macrolide efflux gene mef(A) in Streptococcus pneumoniae. Antimicrob Agents Chemother 2000, 44:2585-2587. 10.1128/AAC.44.9.2585-2587.2000, 90116, 10952626.
25. Santagati M, Iannelli F, Cascone C, Campanile F, Oggioni MR, Stefani S, Pozzi G. The novel conjugative transposon Tn1207.3 carries the macrolide efflux gene mef(A) in Streptococcus pyogenes. Microb Drug Resist 2003, 9:243-247. 10.1089/107662903322286445, 12959402.
26. Del Grosso M, Camilli R, Iannelli F, Pozzi G, Pantosti A. The mef(E)-carrying genetic element (mega) of Streptococcus pneumoniae: insertion sites and association with other genetic elements. Antimicrob Agents Chemother 2006, 50:3361-3366. 10.1128/AAC.00277-06, 1610078, 17005818.
27. Varaldo PE, Montanari MP, Giovanetti E. Genetic elements responsible for erythromycin resistance in streptococci. Antimicrob Agents Chemother 2009, 53:343-353. 10.1128/AAC.00781-08, 2630629, 19001115.
28. Paraskakis I, Kafetzis DA, Chrisakis A, Papavasilliou H, Kirikou H, Pangalis A, Tzouvelekis LS, Athanasiou T, Legakis NJ, . on behalf of the National Surveillance Network for Pneumococcal Resistance Serotypes and antimicrobial susceptibilities of 1033 pneumococci isolated from children in Greece during 2001-2004. Clin Microbiol Infect 2006, 12:490-493. 10.1111/j.1469-0691.2006.01383.x, 16643530, on behalf of the National Surveillance Network for Pneumococcal Resistance.
29. Souli M, Volonakis K, Kapaskelis A, Galani I, Grammelis V, Vorou R, Tsivra M, Chryssouli Z, Katsala D, Giamarellou H. Characterisation of macrolide-non-susceptible Streptococcus pneumoniae colonising children attending day-care centres in Athens, Greece during 2000 and 2003. Clin Microbiol Infect 2007, 13:70-77. 10.1111/j.1469-0691.2006.01555.x, 17184290.
30. Grivea IN, Tsantouli AG, Chryssanthopoulou DC, Syrogiannopoulos GA. Interaction of the heptavalent pneumococcal conjugate vaccine and the use of individual antibiotics among children on nasopharyngeal colonization with erythromycin-resistant Streptococcus pneumoniae. Eur J Clin Microbiol Infect Dis 2010, 29:97-105. 10.1007/s10096-009-0826-1, 19941021.
31. Hellenic National Committee for Immunization Programs National Immunization Program. Paediatriki 2006, 69:78-82. Hellenic National Committee for Immunization Programs.
32. Syrogiannopoulos GA, Grivea IN, Davies TA, Katopodis GD, Appelbaum PC, Beratis NG. Antimicrobial use and colonization with erythromycin-resistant Streptococcus pneumoniae in Greece during the first 2 years of life. Clin Infect Dis 2000, 31:887-893. 10.1086/318118, 11049766.
33. Clinical and Laboratory Standards Institute (CLSI) Performance Standards for Antimicrobial Susceptibility Testing; Eighteenth Informational Supplement. CLSI document M100-S18 2008, Wayne, PA: CLSI, Clinical and Laboratory Standards Institute (CLSI).
34. European Committee on Antimicrobial Testing (EUCAST) Breakpoints tables for interpretation of MICs and zone diameters. Version 2.0 2012, http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_tables/Breakpoint_table_v_2.0_120221.pdf, European Committee on Antimicrobial Testing (EUCAST).
35. Sutcliffe J, Grebe T, Tait-Kamradt A, Wondrack L. Detection of erythromycin-resistant determinants by PCR. Antimicrob Agents Chemother 1996, 40:2562-2566. 163576, 8913465.
36. Reinert RR, Lütticken R, Bryskier A, Al-Lahham A. Macrolide-resistant Streptococcus pneumoniae and Streptococcus pyogenes in the pediatric population in Germany during 2000-2001. Antimicrob Agents Chemother 2003, 47:489-493. 10.1128/AAC.47.2.489-493.2003, 151724, 12543648.
37. American Academy of Pediatrics Pneumococcal infections. Red Book: 2009 Report of the Committee on Infectious Diseases 2009, 524-535. Elk Grove Village, IL: American Academy of Pediatrics, Pickering LK, Baker CJ, Kimberlin DW, Long SS, 28, American Academy of Pediatrics.
38. Syrogiannopoulos GA, Grivea IN, Beratis NG, Spiliopoulou AE, Fasola EL, Bajaksouzian S, Appelbaum PC, Jacobs MR. Resistance patterns of Streptococcus pneumoniae from carriers attending day-care centers in Southwestern Greece. Clin Infect Dis 1997, 25:188-194. 10.1086/514526, 9332508.
39. Bogaert D, Hermans PWM, Grivea IN, Katopodis G, Mitchell TJ, Sluijter M, de Groot R, Beratis NG, Syrogiannopoulos GA. Molecular epidemiology of penicillin-susceptible non-β-lactam-resistant Streptococcus pneumoniae isolates from Greek children. J Clin Microbiol 2003, 41:5633-5639. 10.1128/JCM.41.12.5633-5639.2003, 308965, 14662953.
40. Maraki S, Samonis G, Galanakis E. Serotypes and susceptibilities of paediatric clinical isolates of Streptococcus pneumoniae in Crete, Greece, before and after the heptavalent pneumococcal conjugate vaccine. Eur J Clin Microbiol Infect Dis 2010, 29:1449-1451. 10.1007/s10096-010-1005-0, 20617352.
41. Sá-Leão R, Nunes S, Brito-Avô A, Frazão N, Simões AS, Crisóstomo MI, Paulo ACS, Saldanha J, Santos-Sanches I, de Lencastre H. Changes in pneumococcal serotypes and antibiotypes carried by vaccinated and unvaccinated day-care centre attendees in Portugal, a country with widespread use of the seven-valent pneumococcal conjugate vaccine. Clin Microbiol Infect 2009, 15:1002-1007. 10.1111/j.1469-0691.2009.02775.x, 19392883.
42. Hanage WP, Bishop CJ, Huang SS, Stevenson AE, Pelton SI, Lipsitch M, Finkelstein JA. Carried pneumococci in Massachusetts children. The contribution of clonal expansion and serotype switching. Pediatr Infect Dis J 2011, 30:302-308. 10.1097/INF.0b013e318201a154, 3175614, 21085049.
43. Ardanuy C, Fenoll A, Berrón S, Calatayud L, Liñares J, . and the Spanish Pneumococcal Infection Study Network Increase of the M phenotype among erythromycin-resistant Streptococcus pneumoniae isolates from Spain related to the serotype 14 variant of the Spain9V-3 clone. Antimicrob Agents Chemother 2006, 50:3162-3165. 10.1128/AAC.00269-06, 1563508, 16940119, and the Spanish Pneumococcal Infection Study Network.
44. Sogstad MK, Littauer P, Aaberge IS, Caugant DA, Høiby A. Rapid spread in Norway of an erythromycin-resistant pneumococcal clone, despite low usage of macrolides. Microb Drug Resist 2007, 13:29-36. 10.1089/mdr.2006.9994, 17536931.
45. Bowers JR, Driebe EM, Nibecker JL, Wojack BR, Sarovich DS, Wong AH, Brzoska PM, Hubert N, Knadler A, Watson LM, Wagner DM, Furtado MR, Saubolle M, Engelthaler DM, Keim PS. Dominance of multidrug resistant CC271 clones in macrolide-resistant Streptococcus pneumoniae in Arizona. BMC Microbiol 2012, 12:12. 10.1186/1471-2180-12-12, 3285076, 22251616.
46. Aguiar SI, Brito MJ, Gonçalo-Marques J, Melo-Cristino J, Ramirez M. Serotypes 1, 7F and 19A became the leading causes of pediatric invasive pneumococcal infections in Portugal after 7 years of heptavalent conjugate vaccine use. Vaccine 2010, 28:5167-5173. 10.1016/j.vaccine.2010.06.008, 20558247.
47. Rückinger S, van der Linden M, Reinert RR, von Kries R, Burckhardt F, Siedler A. Reduction in the incidence of invasive pneumococcal disease after general vaccination with 7-valent pneumococcal conjugate vaccine in Germany. Vaccine 2009, 27:4136-4141. 10.1016/j.vaccine.2009.04.057, 19406190.
48. McGee L, Klugman KP, Wasas A, Capper T, Brink A, . and the Antibiotics Surveillance Forum of South Africa Serotype 19F multiresistant pneumococcal clone harboring two erythromycin resistance determinants [erm(B) and mef(A)] in South Africa. Antimicrob Agents Chemother 2001, 45:1595-1598. 10.1128/AAC.45.5.1595-1598.2001, 90516, 11302838, and the Antibiotics Surveillance Forum of South Africa.
49. Farrell DJ, Morrissey I, Bakker S, Morris L, Buckridge S, Felmingham D. Molecular epidemiology of multiresistant Streptococcus pneumoniae with both erm(B) and mef(A)-mediated macrolide resistance. J Clin Microbiol 2004, 42:764-768. 10.1128/JCM.42.2.764-768.2004, 344484, 14766850.
50. Farrell DJ, Jenkins SG, Brown SD, Patel M, Lavin BS, Klugman KP. Emergence and spread of Streptococcus pneumoniae with erm(B) and mef(A) resistance. Emerg Infect Dis 2005, 11:851-858. 10.3201/eid1106.050222, 3367592, 15963279.
51. Eskola J, Kilpi T, Palmu A, Jokinen J, Haapakoski J, Herva E, Takala A, Käyhty H, Karma P, Kohberger R, Siber G, Mäkela PH. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med 2001, 344:403-409. 10.1056/NEJM200102083440602, 11172176.
52. Ekström N, Åhman H, Verho J, Jokinen J, Väkeväinen M, Kilpi T, Käyhty H. Kinetics and avidity of antibodies evoked by heptavalent pneumococcal vaccines PncCRM and PncOMPC in the Finnish otitis media vaccine trial. Infect Immun 2005, 73:369-377. 10.1128/IAI.73.1.369-377.2005, 538941, 15618174.
53. Xu X, Cai L, Xiao M, Kong F, Oftadeh S, Zhou F, Gilbert GL. Distribution of serotypes, genotypes, and resistance determinants among macrolide-resistant Streptococcus pneumoniae isolates. Antimicrob Agents Chemother 2010, 54:1152-1159. 10.1128/AAC.01268-09, 2825966, 20065057.